The company offers comprehensive M&A advisory, IT transformation and project management services, specialising in the growing pharma and medtech industries.

At present, the business is committed to delivering better value for patients by designing and driving strategic projects within life sciences companies, utilising a highly experienced team to deliver effective, bespoke solutions for global organisations.

The owner is now exploring options relating to a partial or full sale of the company, with access to the capabilities of a global organisation enabling the business to capitalise on all available opportunities and achieve accelerated expansion.

Key Highlights

– Through its innovative approach and focus on creative problem solving, the company has successfully delivered a multitude of complex projects and is renowned as a trusted partner amongst clients.

– Predominantly operates in the life sciences market, with clients including multinational organisations that operate within the healthcare, medical device and pharma spaces.

– Maintains strong, direct relationships with clients, several of which span over three years, and operates on an international basis, delivering global projects across 80+ countries.

– Long-standing, diverse and highly skilled London-based workforce in place, with the Company’s continued investment in the development of its team contributing to its excellent retention rates.

– The company has a London-based team that operates with a flexible working arrangement and meeting regularly at an office based in Central London. Teams also work from client locations, as required.

Financial Highlights

– Achieved turnover of circa £1.1 million in YE23, with an adjusted EBITDA of £625k.

– Turnover is projected to rise to £1.3 million in YE24, with adjusted EBITDA also expected to rise to £775k.

– Maintains strong gross profit and adjusted EBITDA margins, averaging 71% and 51%, respectively, across the last three years.

– The enduring strength of the life sciences market, combined with the company’s demonstrable capabilities and increasing prominence, ensures that future revenue is secure, as the business continues to experience consistent, year-on-year growth alongside its clients.

– Strong pipeline in place for the coming year, having secured ongoing contracts with a number of high-value clients.